The RARE Patient Advocacy Summit is the can’t-miss event of the year for rare disease stakeholders and is the largest gathering of rare disease patients, advocates and thought leaders worldwide.
Take advantage of this opportunity to connect and learn from more than 100 experts in rare disease leading educational sessions in four specialized learning tracks:
- Living with a Life-Altering Condition
- Architecting Your Disease Community
- Patients as Partners and Drivers
- Science and Technology Innovation
An invitation-only, off-the-record forum that brings together industry leaders to network and share expertise in Neuro therapeutics.Find out more »
Advances in Clinical Trial Technology: Impact on Methodology and Signal DetectionFind out more »
During the 2018 NORD Rare Summit, over 700 leaders from FDA, NIH, industry, patient groups, payers and research institutions will address the New Era of Patient-Focused Innovation. Together, NORD Rare Summit attendees will explore the new and innovative ways in which patients and caregivers are helping drive progress for the rare disease community.Find out more »
The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments.Find out more »
CNS Summit is a platform for change and a community passionate about shaping the future, with a focus on collaboration, innovation, and technology.Find out more »
Join us for the Ninth Annual Fall Symposium & Luncheon “Hope on the Horizon.” This event comprises a morning symposium with leading Alzheimer’s researchers and a luncheon to present the Charles Evans Award.Find out more »
ISPOR is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in healthcare decisions. If you want to meet professionals in the HEOR field, discuss the latest trends, and learn from the renowned experts, attend ISPOR Barcelona.
ISPOR Barcelona will feature three thought-provoking plenary sessions and more than 2500 presentations in the form of workshops, issue panels, forums, symposia, and podium and poster presentations on innovative research methods, health policy development using outcomes research, patient preferences, real-world data, and clinical-, economic-, and patient-reported outcomes.Find out more »
Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Artificial Intelligence (AI), Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, and Biospecimens and Central Lab Solutions.Find out more »
Exclusively focusing on empowering translational neurodegenerative research, the 7th Annual World CNS Summit is the only industry-specific conference to help bridge the gap for translational development.
Bringing together over 100 senior scientists and executives from across biopharma and academia, join us to challenge traditional thinking in the development of efficacious treatments against neurodegeneration.
This is a unique opportunity to engage with the leading minds in the neurodegenerative space from academia, pharma, biotech and leading consortia to advance the successful development of the next generation of therapies.Find out more »
AD/PD 2019, the 14th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
AD/PD 2019, the 14th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, will build on the well-earned reputation of previous AD/PD Conferences for unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and other related neurodegenerative diseases.
Renowned for its broad, multidisciplinary approach, it uniquely brings together Alzheimer’s Conferences and Parkinson’s Conferences, through exploring overlaps and congruent results, to provide attendees unparalleled and powerful insights into all the latest research and developments, clinical trials, and treatments.
AD/PD is the conference for all those engaged in the neurodegeneration field, from basic scientists to clinical investigators, and from established leaders to young upcoming talents. AD/PD is your opportunity to present your findings at the international level.Find out more »